Establishment profile
SPI PHARMA
40 CAPE HENLOPEN DRIVE, LEWES, DE, 19958
325412 — Pharmaceutical Preparation Manufacturing
Summary
SPI PHARMA has accumulated 1 OSHA violation across 2 inspections over 19 years of recorded history, with $2,025 in total assessed penalties.
The most recent federal enforcement activity was recorded 11 years ago.
Federal records were found in 2 of 16 sources. Sources without matching records returned empty for this establishment.
Agency coverage
SPI PHARMA appears in OSHA workplace safety and EPA environmental compliance records only. No matching records were found in WHD wage enforcement, MSHA mine safety, NLRB labor relations, OFLC visa and labor certification, FMCSA motor carrier registration, SAM.gov federal debarment, CMS nursing home enforcement, UVA Corporate Prosecution Registry, CPSC product recalls, or NHTSA vehicle recalls.
OSHA workplace safety
50% of inspections at this establishment produced violations,
Safety self-report (OSHA 300A)
Recordable injury rates the employer filed with OSHA’s Injury Tracking Application. DART covers cases with days away, restricted, or transferred; TRIR is the total recordable case rate.
Reported for 80 average annual employees at this establishment.
Source: OSHA ITA Form 300A (employer self-reported). Rates are per 100 full-time equivalent workers. Establishments below the ~10-FTE threshold are not required to report.
Industry benchmark
BLS rates reflect industry-wide averages. Self-reported figures come from OSHA’s Injury Tracking Application; absence of self-reported data does not necessarily indicate non-compliance — many establishments fall below the ITA reporting threshold.
Inspection breakdown
Complaint- and accident-triggered inspections are stronger risk signals than routine planned inspections.
OSHA severe injury reports
Self-reported events under 29 CFR 1904.39 (24-hour notification of hospitalization, amputation, or loss of an eye) · Oct 2016
Most frequent event: Struck by dislodged flying object, particle
Source: OSHA Severe Injury Reports (federal OSHA only; state-plan states like California, Oregon, and Washington maintain their own programs and do not consistently report into this feed).
Severe injury reports — events
Each row is a hospitalization, amputation, or eye-loss event the employer self-reported to OSHA under 29 CFR 1904.39. Narratives are written by the reporting employer.
| Date | Event | Body part | Outcome | |
|---|---|---|---|---|
| Oct 12, 2016 | Struck by dislodged flying object, particle | Multiple face locations | Hospitalized |
Source: OSHA Severe Injury Reports. Federal-OSHA jurisdiction only by default; some state-plan programs report voluntarily.
Activity timeline
No federal enforcement activity has been recorded against this establishment in 11+ years. Most recent activity: 11 years ago. Data on this page is refreshed weekly.
Wage & Hour Division (WHD)
No WHD wage, overtime, or child-labor enforcement cases on file for SPI PHARMA. Verify directly with Wage and Hour Division →
Mine safety (MSHA)
No MSHA mine safety violations on file for SPI PHARMA. Verify directly with Mine Safety and Health Administration →
Labor relations (NLRB)
No NLRB unfair labor practice charges or union representation cases on file for SPI PHARMA. Verify directly with National Labor Relations Board →
Visa & labor certification (OFLC)
No H-1B, H-2A, or H-2B labor condition applications on file for SPI PHARMA. Verify directly with Office of Foreign Labor Certification →
Environmental compliance (EPA)
EPA Enforcement and Compliance History — Clean Air Act, Clean Water Act, RCRA, Safe Drinking Water Act. Status: Violation Identified.
Federal criminal prosecution record
No federal criminal prosecutions, plea agreements, or deferred-prosecution agreements on file for SPI PHARMA. Verify directly with UVA Corporate Prosecution Registry →
Inspection history
| Date | Trigger | Violations | Serious | Penalty | |
|---|---|---|---|---|---|
| 2014-08-18 | Complaint | 1 | — | $2,025 | |
| 2007-04-25 | Planned | 0 | — | $0 |
Source: OSHA IMIS. Citation amounts reflect initially assessed penalties; final amounts after appeal may differ.
In the news
Other employers in this industry and state
Other employers in pharmaceutical preparation manufacturing within DE, ordered by federal enforcement volume:
- NORAMCO OF DELAWARE INC.WILMINGTON — 1 federal enforcement record
- MARLEX PHARMACEUTICALSNEW CASTLE — 1 federal enforcement record
Related searches
- Pharmaceutical Preparation ManufacturingAll employers in this industry
- Employers in DEState-wide enforcement data
- Pharmaceutical Preparation Manufacturing in DEIndustry × state cross-filter
Need API access, bulk download, or licensed redistribution? The website is free. Programmatic and licensed access is handled separately.
Contact sales →About this data
This profile aggregates federal enforcement records on SPI PHARMA from every major federal compliance and enforcement source plus the UVA Corporate Prosecution Registry. OSHA workplace safety inspections, WHD wage cases, MSHA mine safety, EPA environmental enforcement, NLRB labor relations, OFLC visa/labor certification, FMCSA motor carrier registration, SAM.gov debarments, CMS nursing-home records, BLS industry safety benchmarks, OSHA ITA self-reported injury rates, SEC enforcement and financial disclosures, CPSC and NHTSA recalls.
Establishments are matched across agencies using normalized employer name, state, and ZIP code.
OSHA citations typically appear 3–8 months after the inspection, so very recent enforcement actions may not yet be reflected. Profiles may be incomplete if the establishment operates under multiple legal names or files under variations our entity-matching rules don’t yet cover. To report a missing record or correction, email corrections@fastdol.com.
Frequently asked
- What is SPI PHARMA's OSHA violation history?
- SPI PHARMA has 2 OSHA inspections on record with 1 violation and $2,025 in total penalties.
- How does SPI PHARMA's safety record compare to its industry?
- SPI PHARMA operates in the pharmaceutical preparation manufacturing industry. The industry average Total Recordable Incident Rate (TRIR) is 1.4. SPI PHARMA's self-reported DART rate is 0 compared to an industry average of 0.9.